An outgrowth of longtime SBIR Involved Giner, Giner Life Sciences is a startup medical device company focused on the development of fully implantable systems that enable cellular therapeutics without the need for immune suppression. The firm's first product targets Type 1 Diabetes and is being designed to provide natural, long term insulin regulation using a small device implanted under the skin. This revolutionary treatment will work for both children and adults, with no more blood testing multiple times every day and no dread of hypoglycemic episodes overnight
